Logo image of MSEX

MIDDLESEX WATER CO (MSEX) Stock Fundamental Analysis

NASDAQ:MSEX - Nasdaq - US5966801087 - Common Stock - Currency: USD

60.36  -2.43 (-3.87%)

After market: 60.36 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MSEX. MSEX was compared to 14 industry peers in the Water Utilities industry. MSEX has a medium profitability rating, but doesn't score so well on its financial health evaluation. MSEX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

MSEX had positive earnings in the past year.
In the past year MSEX had a positive cash flow from operations.
In the past 5 years MSEX has always been profitable.
MSEX had a positive operating cash flow in each of the past 5 years.
MSEX Yearly Net Income VS EBIT VS OCF VS FCFMSEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

MSEX's Return On Assets of 3.52% is fine compared to the rest of the industry. MSEX outperforms 64.29% of its industry peers.
MSEX has a Return On Equity of 9.90%. This is comparable to the rest of the industry: MSEX outperforms 50.00% of its industry peers.
With a Return On Invested Capital value of 3.52%, MSEX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MSEX is below the industry average of 5.20%.
The last Return On Invested Capital (3.52%) for MSEX is above the 3 year average (3.15%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.52%
ROE 9.9%
ROIC 3.52%
ROA(3y)3.33%
ROA(5y)3.5%
ROE(3y)9.27%
ROE(5y)9.73%
ROIC(3y)3.15%
ROIC(5y)3.07%
MSEX Yearly ROA, ROE, ROICMSEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 23.06%, MSEX is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
In the last couple of years the Profit Margin of MSEX has declined.
MSEX's Operating Margin of 27.73% is in line compared to the rest of the industry. MSEX outperforms 50.00% of its industry peers.
MSEX's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.73%
PM (TTM) 23.06%
GM N/A
OM growth 3Y6.13%
OM growth 5Y1.01%
PM growth 3Y-3.22%
PM growth 5Y-1.69%
GM growth 3YN/A
GM growth 5YN/A
MSEX Yearly Profit, Operating, Gross MarginsMSEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MSEX is destroying value.
The number of shares outstanding for MSEX has been increased compared to 1 year ago.
MSEX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MSEX has been reduced compared to a year ago.
MSEX Yearly Shares OutstandingMSEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MSEX Yearly Total Debt VS Total AssetsMSEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.28, we must say that MSEX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MSEX (1.28) is better than 71.43% of its industry peers.
A Debt/Equity ratio of 0.84 indicates that MSEX is somewhat dependend on debt financing.
The Debt to Equity ratio of MSEX (0.84) is better than 64.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z 1.28
ROIC/WACC0.44
WACC8.03%
MSEX Yearly LT Debt VS Equity VS FCFMSEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

MSEX has a Current Ratio of 0.52. This is a bad value and indicates that MSEX is not financially healthy enough and could expect problems in meeting its short term obligations.
MSEX's Current ratio of 0.52 is on the low side compared to the rest of the industry. MSEX is outperformed by 78.57% of its industry peers.
MSEX has a Quick Ratio of 0.52. This is a bad value and indicates that MSEX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.44, MSEX is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.44
MSEX Yearly Current Assets VS Current LiabilitesMSEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 19.31% over the past year.
MSEX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.31% yearly.
Looking at the last year, MSEX shows a quite strong growth in Revenue. The Revenue has grown by 15.40% in the last year.
MSEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.35% yearly.
EPS 1Y (TTM)19.31%
EPS 3Y6.07%
EPS 5Y4.31%
EPS Q2Q%-10.17%
Revenue 1Y (TTM)15.4%
Revenue growth 3Y10.27%
Revenue growth 5Y7.35%
Sales Q2Q%9.32%

3.2 Future

The Earnings Per Share is expected to grow by 5.92% on average over the next years.
The Revenue is expected to grow by 7.45% on average over the next years.
EPS Next Y4.62%
EPS Next 2Y5.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.3%
Revenue Next 2Y7.45%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MSEX Yearly Revenue VS EstimatesMSEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
MSEX Yearly EPS VS EstimatesMSEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

1

4. Valuation

4.1 Price/Earnings Ratio

MSEX is valuated quite expensively with a Price/Earnings ratio of 25.05.
Compared to the rest of the industry, the Price/Earnings ratio of MSEX is on the same level as its industry peers.
MSEX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.18.
A Price/Forward Earnings ratio of 21.78 indicates a rather expensive valuation of MSEX.
Based on the Price/Forward Earnings ratio, MSEX is valued a bit cheaper than 64.29% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MSEX to the average of the S&P500 Index (20.81), we can say MSEX is valued inline with the index average.
Industry RankSector Rank
PE 25.05
Fwd PE 21.78
MSEX Price Earnings VS Forward Price EarningsMSEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

MSEX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. MSEX is more expensive than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.68
MSEX Per share dataMSEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MSEX does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.43
PEG (5Y)5.81
EPS Next 2Y5.92%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

MSEX has a Yearly Dividend Yield of 2.17%. Purely for dividend investing, there may be better candidates out there.
MSEX's Dividend Yield is slightly below the industry average, which is at 3.29.
Compared to an average S&P500 Dividend Yield of 2.45, MSEX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.17%

5.2 History

On average, the dividend of MSEX grows each year by 6.43%, which is quite nice.
MSEX has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of MSEX decreased in the last 3 years.
Dividend Growth(5Y)6.43%
Div Incr Years2
Div Non Decr Years2
MSEX Yearly Dividends per shareMSEX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

53.16% of the earnings are spent on dividend by MSEX. This is a bit on the high side, but may be sustainable.
The dividend of MSEX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP53.16%
EPS Next 2Y5.92%
EPS Next 3YN/A
MSEX Yearly Income VS Free CF VS DividendMSEX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M
MSEX Dividend Payout.MSEX Dividend Payout, showing the Payout Ratio.MSEX Dividend Payout.PayoutRetained Earnings

MIDDLESEX WATER CO

NASDAQ:MSEX (5/2/2025, 8:11:17 PM)

After market: 60.36 0 (0%)

60.36

-2.43 (-3.87%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryWater Utilities
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners78.75%
Inst Owner Change1.05%
Ins Owners1.18%
Ins Owner Change8.46%
Market Cap1.08B
Analysts50
Price Target67.66 (12.09%)
Short Float %2.93%
Short Ratio2.76
Dividend
Industry RankSector Rank
Dividend Yield 2.17%
Yearly Dividend1.32
Dividend Growth(5Y)6.43%
DP53.16%
Div Incr Years2
Div Non Decr Years2
Ex-Date05-15 2025-05-15 (0.34)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.48%
Min EPS beat(2)15.34%
Max EPS beat(2)31.61%
EPS beat(4)3
Avg EPS beat(4)15.43%
Min EPS beat(4)-9.62%
Max EPS beat(4)31.61%
EPS beat(8)3
Avg EPS beat(8)-7.02%
EPS beat(12)4
Avg EPS beat(12)-8.01%
EPS beat(16)5
Avg EPS beat(16)-9.48%
Revenue beat(2)2
Avg Revenue beat(2)5.25%
Min Revenue beat(2)3.09%
Max Revenue beat(2)7.4%
Revenue beat(4)2
Avg Revenue beat(4)-0.7%
Min Revenue beat(4)-10.82%
Max Revenue beat(4)7.4%
Revenue beat(8)2
Avg Revenue beat(8)-5.72%
Revenue beat(12)2
Avg Revenue beat(12)-5.07%
Revenue beat(16)2
Avg Revenue beat(16)-4.77%
PT rev (1m)6.42%
PT rev (3m)8.74%
EPS NQ rev (1m)2.7%
EPS NQ rev (3m)14%
EPS NY rev (1m)-0.46%
EPS NY rev (3m)5.41%
Revenue NQ rev (1m)-3.86%
Revenue NQ rev (3m)-2.14%
Revenue NY rev (1m)-2.7%
Revenue NY rev (3m)2.16%
Valuation
Industry RankSector Rank
PE 25.05
Fwd PE 21.78
P/S 5.63
P/FCF N/A
P/OCF 18.39
P/B 2.42
P/tB 2.42
EV/EBITDA 17.68
EPS(TTM)2.41
EY3.99%
EPS(NY)2.77
Fwd EY4.59%
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)3.28
OCFY5.44%
SpS10.73
BVpS24.98
TBVpS24.98
PEG (NY)5.43
PEG (5Y)5.81
Profitability
Industry RankSector Rank
ROA 3.52%
ROE 9.9%
ROCE 4.54%
ROIC 3.52%
ROICexc 3.53%
ROICexgc 3.53%
OM 27.73%
PM (TTM) 23.06%
GM N/A
FCFM N/A
ROA(3y)3.33%
ROA(5y)3.5%
ROE(3y)9.27%
ROE(5y)9.73%
ROIC(3y)3.15%
ROIC(5y)3.07%
ROICexc(3y)3.16%
ROICexc(5y)3.08%
ROICexgc(3y)3.16%
ROICexgc(5y)3.08%
ROCE(3y)4.13%
ROCE(5y)3.98%
ROICexcg growth 3Y9.39%
ROICexcg growth 5Y1.66%
ROICexc growth 3Y9.39%
ROICexc growth 5Y1.66%
OM growth 3Y6.13%
OM growth 5Y1.01%
PM growth 3Y-3.22%
PM growth 5Y-1.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Debt/EBITDA 4.63
Cap/Depr 266.15%
Cap/Sales 38.89%
Interest Coverage 3.67
Cash Conversion 72.28%
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.44
Altman-Z 1.28
F-Score7
WACC8.03%
ROIC/WACC0.44
Cap/Depr(3y)301.61%
Cap/Depr(5y)341.57%
Cap/Sales(3y)49.79%
Cap/Sales(5y)55.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.31%
EPS 3Y6.07%
EPS 5Y4.31%
EPS Q2Q%-10.17%
EPS Next Y4.62%
EPS Next 2Y5.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.4%
Revenue growth 3Y10.27%
Revenue growth 5Y7.35%
Sales Q2Q%9.32%
Revenue Next Year8.3%
Revenue Next 2Y7.45%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.66%
EBIT growth 3Y17.03%
EBIT growth 5Y8.43%
EBIT Next Year65.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.27%
OCF growth 3Y21.15%
OCF growth 5Y10.25%